dihexa cancer risk c-met

dihexa cancer risk c-met hgf HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth – c-Met Signaling as a Therapeutic

Name: dihexa cancer risk c-met hgf HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth – c-Met Signaling as a Therapeutic
Brand: crisbcreativa.com
SKU: 5129325228
Price: 22.54 USD
Availability: InStock
Rating: 4.0477 (23 reviews)

c Met Signaling as a Therapeutic Target in Head : The Cancer Journal Targeting c MET in gastrointestinal tumours: rationale, opportunities and challenges Nature Reviews Clinical Oncology Targeting c MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications Dihexa: Enhancing Cognitive Function Effectively Dihexa targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the c MET receptor, it helps cells take in nutrients and rebuildespecially in cases where recovery is

SKU: 5129325228 · From crisbcreativa.com

4.0

USD22.54 USD62.54

Pay in 4 interest-free payments of $5.63 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

BPC-157 Body Protection Compound CAS: 137525-51-0 Formula: C 62 H 98 N 16 O 22 M.W.: 1419.556 g/mol Purity: 99%+ Ref No.:BOC-0005VI Ref No.:BOC-0010VI For Research Use Only (RUO) Not for human or veterinary use